IMPLEMENTATION OF THERAPEUTIC DRUG MONITORING IN INDONESIA

  • Aluwi Nirwana Sani STIKes Medistra Indonesia
Keywords: Drug concentration, drug monitoring, patient, blood samples

Abstract

Therapeutic Drug Monitoring (TDM) is the clinical pharma    cy practice of measuring plasma level of drugs. This service is required to optimize the drug therapy in individual patient and should be considered an adjunct to physician’s clinical judgment in assessing the course and the effectiveness of treatment, especially in critically ill patients. Indonesia has not been developed this service. Therefore, this article discus the roles and function of a best practice TDM service and how can this service be implemented in Indonesia.

References

[1] PedersenL et al.2021. Evaluation of Therapeutic Drug Monitoring in the Clinical Management of patients with Rheumatic Disease: Data from a Retrospective Single-Centre Cohort Study. Biologic Targets and Therapy. V14
[2] Javadi SS etal.2018. Correlation between measured and calculated free phenytoin serum concentration in neurointensive care patients with hypoalbuminea.Clin.Pharmacol Vol.10
[3] Rianto S.2011. Therapeutic Drug Monitoring: Focus on Conditions in Indonesia. Acta Med. Indones-Indonesia J Internn Med V.43 No.3
[4] Kang JS and Lee MH. 2009. Overview of Therapeutic Drug Monitoring.KJIM.V.24
[5] Ghiculescu RA, 2008. Thepeutic drug monitoring: which drugs, why, when and how to do it,Australian Prescriber, Vol 31
[6] Annette SG. 1998. Best practice in drug monitoring. Br J Pharmacol. 46:95-99
[7] Birkett D, 1997. Pharmacokinetics made easy: Therapeutic drug monitoring, Australian Prescriber
Published
2021-08-31